Dr. Oliver Distler |
| ISN Medical Advisory Board |
| My research group is working in the field of molecular biology to identify molecular targets for therapy in systemic sclerosis. |
My name is Dr. Oliver Distler and I am serving on the medical advisory board of ISN. I am heading the scleroderma outpatient clinic at the University of Zurich, Switzerland. Next to my medical duties, my research group is working in the field of molecular biology to identify molecular targets for therapy in systemic sclerosis. This resulted for example in the identification of imatinib (Gleevec) as a potential therapy for scleroderma, which is currently being tested in clinical trials. How did I get in contact with scleroderma as a medical speciality? This was more than twelve years ago, when the German scleroderma self help group provided research grants for young medical doctors to conduct research in scleroderma. Ever since then I have continued my research on scleroderma. Department of Rheumatology |
| Related Links |
| Welcome Dr. Oliver Distler: ISN Medical Advisory Board |
| Dr. Oliver Distler: ISN Medical Advisory Board. I am heading the scleroderma outpatient clinic at the University of Zurich, Switzerland. Next to my medical duties, my research group is working in the field of molecular biology to identify molecular targets for therapy in systemic sclerosis. This resulted for example in the identification of imatinib (Gleevec) as a potential therapy for scleroderma, which is currently being tested in clinical trials. Posted 03-30-08. |
| Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts. A body of evidence has accumulated illustrating that rheumatoid arthritis synovial fibroblasts are active drivers of joint destruction in rheumatoid arthritis. Ulf Müller-Ladner, Caroline Ospelt, Steffen Gay, Oliver Distler, and Thomas Pap, Arthritis Research & Therapy 2007, 9(6): 223. (Also see: Rheumatoid Arthritis and Prof. Ulf Müller-Ladner, MD: ISN Medical Advisory Board ) |
|
||||||||||||
| Go to Doom, Sheryl | ||||||||||||
|
||||||||||||